These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Population pharmacokinetics and dose-response relationship of levetiracetam in adult patients with epilepsy. Rhee SJ; Shin JW; Lee S; Moon J; Kim TJ; Jung KY; Park KI; Lee ST; Jung KH; Yu KS; Jang IJ; Chu K; Lee SK Epilepsy Res; 2017 May; 132():8-14. PubMed ID: 28279893 [TBL] [Abstract][Full Text] [Related]
9. Cortical cerebrovascular and metabolic perturbations in the 5xFAD mouse model of Alzheimer's disease. Jullienne A; Szu JI; Quan R; Trinh MV; Norouzi T; Noarbe BP; Bedwell AA; Eldridge K; Persohn SC; Territo PR; Obenaus A Front Aging Neurosci; 2023; 15():1220036. PubMed ID: 37533765 [TBL] [Abstract][Full Text] [Related]
11. [ Maruyama H; Gomi M; Lwin TT; Yoneyama A; Sasaki T Ann Nucl Med; 2024 Feb; 38(2):120-130. PubMed ID: 37921921 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic and Pharmacodynamic Evaluation of Intravenous Levetiracetam in Children With Epilepsy. Kim MJ; Yum MS; Yeh HR; Ko TS; Lim HS J Clin Pharmacol; 2018 Dec; 58(12):1586-1596. PubMed ID: 30052270 [TBL] [Abstract][Full Text] [Related]
13. Levetiracetam Pharmacokinetics and Brain Uptake in a Lateral Fluid Percussion Injury Rat Model. Coles LD; Saletti PG; Lisgaras CP; Casillas-Espinosa PM; Liu W; Li Q; Jones NC; Shultz S; Ali I; Brady R; Yamakawa G; Hudson M; Silva J; Braine E; Mishra U; Cloyd JC; O'Brien TJ; Moshé SL; Galanopoulou AS; J Pharmacol Exp Ther; 2023 Aug; 386(2):259-265. PubMed ID: 37316328 [TBL] [Abstract][Full Text] [Related]
14. Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action. Nicolas JM; Hannestad J; Holden D; Kervyn S; Nabulsi N; Tytgat D; Huang Y; Chanteux H; Staelens L; Matagne A; Mathy FX; Mercier J; Stockis A; Carson RE; Klitgaard H Epilepsia; 2016 Feb; 57(2):201-9. PubMed ID: 26663401 [TBL] [Abstract][Full Text] [Related]
15. In vivo evaluation of amyloid deposition and brain glucose metabolism of 5XFAD mice using positron emission tomography. Rojas S; Herance JR; Gispert JD; Abad S; Torrent E; Jiménez X; Pareto D; Perpiña U; Sarroca S; Rodríguez E; Ortega-Aznar A; Sanfeliu C Neurobiol Aging; 2013 Jul; 34(7):1790-8. PubMed ID: 23402900 [TBL] [Abstract][Full Text] [Related]
17. Functional brain imaging: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2006; 6(22):1-79. PubMed ID: 23074493 [TBL] [Abstract][Full Text] [Related]
18. Leveraging genetic diversity in mice to inform individual differences in brain microstructure and memory. Murdy TJ; Dunn AR; Singh S; Telpoukhovskaia MA; Zhang S; White JK; Kahn I; Febo M; Kaczorowski CC Front Behav Neurosci; 2022; 16():1033975. PubMed ID: 36703722 [TBL] [Abstract][Full Text] [Related]
19. Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity: A Randomized Clinical Trial. Vossel K; Ranasinghe KG; Beagle AJ; La A; Ah Pook K; Castro M; Mizuiri D; Honma SM; Venkateswaran N; Koestler M; Zhang W; Mucke L; Howell MJ; Possin KL; Kramer JH; Boxer AL; Miller BL; Nagarajan SS; Kirsch HE JAMA Neurol; 2021 Nov; 78(11):1345-1354. PubMed ID: 34570177 [TBL] [Abstract][Full Text] [Related]
20. Preclinical and clinical study on [ Xu M; Guo J; Gu J; Zhang L; Liu Z; Ding L; Fu H; Ma Y; Liang S; Wang H Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):652-663. PubMed ID: 34292345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]